Healthway Medical Corporation Limited reported group unaudited earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported revenue of SGD 23,164,000 against SGD 24,700,000 a year ago. Loss before income tax was SGD 246,000 against profit of SGD 690,000 a year ago. Loss attributable to shareholders was SGD 504,000 against profit of SGD 580,000 a year ago. Net cash used in operating activities was SGD 4,180,000 against cash generated from operating activities of SGD 3,573,000 a year ago. Addition to of property, plant and equipment was SGD 288,000 against SGD 43,000 a year ago. Diluted and basic loss per ordinary share was 0.02 cents against earning per ordinary share of 0.03 cents a year ago. Net asset value per ordinary share based on total number of issued shares, excluding treasury shares as at March 31, 2017 was 6.17 cents. The decrease in turnover was mainly due to the decrease in revenue of SGD 1.1 million from the Primary Healthcare segment, as well as SGD 0.4 million in Specialist & Wellness Healthcare segment.